PAIN2.0: study protocol for a multicentre randomised controlled trial to evaluate the efficacy of a 10-week outpatient interdisciplinary multimodal pain therapy to manage recurrent pain for patients with risk factors of developing chronic pain in Germany.
Complex intervention
Health-related quality of life
Mixed models for repeated measures
Multimodal interdisciplinary pain management
Outpatient group therapy
Pain and risk factors
Public health
Randomised controlled trial
Recurrent pain
Secondary prevention
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
23 Feb 2024
23 Feb 2024
Historique:
received:
16
11
2023
accepted:
08
02
2024
medline:
24
2
2024
pubmed:
24
2
2024
entrez:
23
2
2024
Statut:
epublish
Résumé
Up to 27% of the German population suffers from recurrent or persistent pain (lasting more than three months). Therefore, prevention of chronic pain is one major object of pain management interventions. The aim of this nationwide, multicentre, randomised controlled trial is to evaluate the efficacy of a 10-week ambulatory (outpatient) interdisciplinary multimodal pain therapy (A-IMPT) for patients with recurrent pain and at risk of developing chronic pain. This project was initiated by the German Pain Society (Deutsche Schmerzgesellschaft e.V.) and the public health insurance provider BARMER. It is currently funded by the German Innovation Fund (01NVF20023). The study PAIN2.0 focuses on reducing pain intensity and pain-related disability and investigates whether this intervention can improve physical activity, psychological well-being, and health literacy. PAIN2.0 is designed as a multicentre 1:1 randomised controlled trial with two parallel groups (randomisation at the patient level, planned N = 1094, duration of study participation 12 months, implemented by 22 health care facilities nationwide). After 6 months, patients within the control group also receive the intervention. The primary outcomes are pain intensity and pain-related impairment, measured as Characteristic Pain Intensity (PI) and Disability Score (DS) (Von Korff), as well as patient-related satisfaction with the intervention. Secondary outcomes are the number of sick leave days, sickness allowance, treatment costs, psychological distress, health-related quality of life, and catastrophizing. The effects of the intervention will be analysed by a parallel-group comparison between the intervention and control groups. In addition, the long-term effects within the intervention group will be observed and a pre-post comparison of the control group before and after the intervention will be performed. Recurrent or persistent pain is common in the German population and causes high costs for patients and society. The A-IMPT aims to improve pain and pain-related impairments in pain patients at risk of chronification, thereby reducing the risk of developing chronic pain with its high socioeconomic burden. This new therapy could easily be integrated into existing therapy programs if positively evaluated. The trial PAIN2.0 has been registered in the German Clinical Trials Register (DRKS) since 21/11/2022 with the ID DRKS00030773 .
Sections du résumé
BACKGROUND
BACKGROUND
Up to 27% of the German population suffers from recurrent or persistent pain (lasting more than three months). Therefore, prevention of chronic pain is one major object of pain management interventions. The aim of this nationwide, multicentre, randomised controlled trial is to evaluate the efficacy of a 10-week ambulatory (outpatient) interdisciplinary multimodal pain therapy (A-IMPT) for patients with recurrent pain and at risk of developing chronic pain. This project was initiated by the German Pain Society (Deutsche Schmerzgesellschaft e.V.) and the public health insurance provider BARMER. It is currently funded by the German Innovation Fund (01NVF20023). The study PAIN2.0 focuses on reducing pain intensity and pain-related disability and investigates whether this intervention can improve physical activity, psychological well-being, and health literacy.
METHODS
METHODS
PAIN2.0 is designed as a multicentre 1:1 randomised controlled trial with two parallel groups (randomisation at the patient level, planned N = 1094, duration of study participation 12 months, implemented by 22 health care facilities nationwide). After 6 months, patients within the control group also receive the intervention. The primary outcomes are pain intensity and pain-related impairment, measured as Characteristic Pain Intensity (PI) and Disability Score (DS) (Von Korff), as well as patient-related satisfaction with the intervention. Secondary outcomes are the number of sick leave days, sickness allowance, treatment costs, psychological distress, health-related quality of life, and catastrophizing. The effects of the intervention will be analysed by a parallel-group comparison between the intervention and control groups. In addition, the long-term effects within the intervention group will be observed and a pre-post comparison of the control group before and after the intervention will be performed.
DISCUSSION
CONCLUSIONS
Recurrent or persistent pain is common in the German population and causes high costs for patients and society. The A-IMPT aims to improve pain and pain-related impairments in pain patients at risk of chronification, thereby reducing the risk of developing chronic pain with its high socioeconomic burden. This new therapy could easily be integrated into existing therapy programs if positively evaluated.
TRIAL REGISTRATION
BACKGROUND
The trial PAIN2.0 has been registered in the German Clinical Trials Register (DRKS) since 21/11/2022 with the ID DRKS00030773 .
Identifiants
pubmed: 38395869
doi: 10.1186/s13063-024-07975-4
pii: 10.1186/s13063-024-07975-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
145Subventions
Organisme : Gemeinsame Bundesausschuss
ID : 01NVF20023
Informations de copyright
© 2024. The Author(s).
Références
German Clinical Trials Register. https://drks.de/search/de/trial/DRKS00030773 . Accessed 13 Sept 2023.
International Association for the Study of Pain. https://www.iasp-pain.org/advocacy/global-year/prevention-of-pain/#:~:text=IASP%20Dedicates%202020%20Global%20Year%20to%20the%20Prevention%20of%20Pain&text=Brona%20Fullen%20and%20Dr.,Esther%20Pogatzki%2DZahn . Accessed 20 Sept 2023.
Wenig CM, Schmidt CO, Kohlmann T, Schweikert B. Costs of back pain in Germany. Eur J Pain. 2009;13:280–6. https://doi.org/10.1016/j.ejpain.2008.04.005 .
doi: 10.1016/j.ejpain.2008.04.005
pubmed: 18524652
Wolff R, Clar C, Lerch C, Kleijnen J. Epidemiology of chronic non-malignant pain in Germany. Der Schmerz. 2011;25:26–44.
doi: 10.1007/s00482-010-1011-2
pubmed: 21336883
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287–333.
doi: 10.1016/j.ejpain.2005.06.009
pubmed: 16095934
Hauser W, Schmutzer G, Hinz A, Hilbert A, Brähler A. Prevalence of chronic pain in Germany. A representative survey of the general population. Schmerz. 2013;27:46–55.
pubmed: 23321703
Dietl M, Korczak D. Over-, under- and misuse of pain treatment in Germany. GMS Health Technol Assess. 2011. https://doi.org/10.3205/hta000094 .
doi: 10.3205/hta000094
pubmed: 21808659
pmcid: 3145353
Kouyanou K, Pither C, Wessely S. Iatrogenic factors and chronic pain. Psychosom Med. 1997;59(6):597–604.
doi: 10.1097/00006842-199711000-00007
pubmed: 9407578
Nicholas MK, Linton SJ, Watson P, Main CJ, Decade of the Flags Working Group. Early identification and management of psychological risk factors (“yellow flags”) in patients with low back pain: a reappraisal. Phys Ther. 2011;91:737–53.
doi: 10.2522/ptj.20100224
pubmed: 21451099
Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976–82.
doi: 10.1097/j.pain.0000000000001939
pubmed: 32694387
pmcid: 7680716
IASP terminology. https://www.iasp-pain.org/resources/terminology/ . Assessed 20 Sept 2023.
Kaiser U, Treede RD, Sabatowski R. Multimodal pain therapy in chronic noncancer pain – gold standard or need for further clarification? Pain. 2017;158(10):1853–9.
doi: 10.1097/j.pain.0000000000000902
pubmed: 28328572
Kaiser U, Petzke F, Nagel B, Marschall U, Casser HR, Isenberg T, Kohlmann T, Lindena G, PAIN2020. Evaluation eines frühen interdisziplinären multimodalen Assessments für Patienten mit Schmerzen. Protokoll einer randomisierten kontrollierten Studie (PAIN2020). Schmerz. 2020; https://doi.org/10.1007/s00482-020-00497-3 .
Müller-Schwefe G, Nadstawek J, ToelleT, Nilges P, Überall MA, et al. Struktur der schmerzmedizinischen Versorgung in Deutschland: Klassifikation schmerzmedizinischer Einrichtungen. Schmerz. 2016;30:2018–226.
Pfingsten M, Arnold B, Böger A, Brinkschmidt T, Casser HR, Irnich D, Kaiser U, Klimczyk K, Lutz J, Schiltenwolf M, Seeger D, Zernikow B, Sabatowski R. Sektorenübergreifende interdisziplinäre multimodale Schmerztherapie. Schmerz. 2019;33:191–203.
doi: 10.1007/s00482-019-0374-2
pubmed: 31073760
Arnold B, Brinkschmidt T, Casser HR, Gralow I, Irnich D, Klimczyk K, Müller G, Nagel B, Pfingsten M, Schiltenwolf M, Sittl R, Söllner W. Multimodale Schmerztherapie – Konzepte und Indikationen [Multimodal pain therapy: principles and indications]. Schmerz. 2009;23:112–20.
doi: 10.1007/s00482-008-0741-x
pubmed: 19156448
Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992;50:133–49.
doi: 10.1016/0304-3959(92)90154-4
Attkisson C, Zwick R. The client satisfaction questionnaire. Psychometric Properties and Correlations with Service Utilization and Psychotherapy Outcome. Evaluation and Program Planning. 1982. https://doi.org/10.1016/0149-7189(82)90074-x .
Schmidt J, Lamprecht F, Wittmann WW. Zufriedenheit mit der stationären Versorgung. Entwicklung eines Fragebogens und erste Validitätsuntersuchungen. [Satisfaction with inpatient care: Development of a questionnaire and first validity assessments.]. Psychother Psychosom Med Psychol. 1989;39(7):248–55.
pubmed: 2762479
Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. Sydney: N.S.W. Psychology Foundation of Australia; 1995.
Nilges P, Essau C. DASS. Depressions-Angst-Stress-Skalen – deutschsprachige Kurzfassung. Trier: ZPID (Leibniz Institute for Psychology) – Open Test Archive. 2021. https://doi.org/10.23668/psycharchives.4579 .
Kazis LE, Miller DR, Skinner KM, Lee A, Ren XS, Clark JA, Rogers WH, Spiro A, Selim AJ, Linzer M, Payne S, Mansell D, Fincke G. Patient-reported measures of health: the veterans’ health study. J Ambul Care Manag. 2004;27:70–83.
doi: 10.1097/00004479-200401000-00012
Kazis LE, Selim A, Rogers W, et al. Dissemination of methods and results from the veterans’ health study: final comments and implications for future monitoring strategies within and outside the veterans’ healthcare system. J Ambul Care Manag. 2006;29:310–9.
doi: 10.1097/00004479-200610000-00007
Buchholz I, Kohlmann T, Buchholz M. Vergleichende Untersuchung der psychometrischen Eigenschaften des SF-36/SF-12 vs. VR-36/VR-12. Abschlussbericht. 2017. https://www.reha-vffr.de/images/vffrpdf/projekte/2017/VR-Abschlussbericht_vffr205.pdf . Accessed 13 Sept 2023.
Buchholz I, Feng YS, Buchholz M, Kazis LE, Kohlmann T. Translation and adaptation of the German version of the Veterans Rand-36/12 Item Health Survey. Health Qual Life Outcomes. 2021;19:137.
doi: 10.1186/s12955-021-01722-y
pubmed: 33947411
pmcid: 8097879
Meyer K, Sprott H, Mannion AF. Cross-cultural adaptation, reliability, and validity of the German version of the Pain Catastrophizing Scale. J Psychosom Res. 2008;64(5):469–78.
doi: 10.1016/j.jpsychores.2007.12.004
pubmed: 18440399
Schulte D. Messung der Therapieerwartung und Therapieevaluation von Patienten (PATHEV). Z Klin Psychol Psychother. 2005;34:176–87.
doi: 10.1026/1616-3443.34.3.176
Finger JD, Tafforeau J, Gisle L, Oja L, Ziese T, Thelen J, Mensink GBM, Lange C. Development of the European Health Interview Survey - Physical Activity Questionnaire (EHIS-PAQ) to monitor physical activity in the European Union. Arch Public Health. 2015;73:59.
doi: 10.1186/s13690-015-0110-z
pubmed: 26634120
pmcid: 4667448
Robert Koch-Institut (Eds). Körperliche Bewegung bei der Arbeit, zur Fortbewegung und in der Freizeit. In: Robert Koch-Institut (Eds). Fragebogen zur Studie “Gesundheit in Deutschland aktuell”: GEDA 2014/2015-EHIS. Journal of Health Monitoring. 2017. https://doi.org/10.17886/RKI-GBE-2017-014 .
Baumeister SE, Ricci C, Kohler S, Fischer B, Töpfer C, Finger JD, Leitzmann MF. Physical activity surveillance in the European Union: reliability and validity of the European Health Interview Survey-Physical Activity Questionnaire (EHIS-PAQ). Int J Behav Nutr Phys Act. 2016;13:61.
doi: 10.1186/s12966-016-0386-6
pubmed: 27215626
pmcid: 4877949
Meyer K. Ausgewählte Konzepte und Instrumente der Eigenschafts- und Verhaltensdiagnostik. In: Persönlichkeit und Selbststeuerung der Generation Z. Wiesbaden: Springer; 2020. https://doi.org/10.1007/978-3-658-32603-6_3 .
Wieland R, Latocha K. Gruppentraining zur Förderung der Gesundheitskompetenz für psychisch erkrankte Beschäftigte in einer Werkstatt für behinderte Menschen, Expertise zur ganzheitlichen Gesundheitsförderung bei proviel GmbH. 2012.
Sudeck G, Pfeifer K. Physical activity-related health competence as an integrative objective in exercise therapy – conception and validation of a short questionnaire. Ger J Exerc Sport Res. 2016;46:74–87.
Browne WJ, Lahi MG, Parker RM. A guide to sample size calculations for random effect models via simulation and the MLPowSim software package. Bristol: University of Bristol; 2009.
Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8:283–91.
doi: 10.1016/j.ejpain.2003.09.004
pubmed: 15207508
German Pain Society [Deutsche Schmerzgesellschaft e.V]. PAIN2.0 - Patientenorientiert. Abgestuft. Interdisziplinär. Netzwerk Therapie. Zuweiser*innen. https://www.pain2punkt0.de/?page_id=433 . Accessed 13 Sept 2023.
German Pain Society [Deutsche Schmerzgesellschaft e.V.]. PAIN2.0 - Patientenorientiert. Abgestuft. Interdisziplinär. Netzwerk Therapie. https://www.pain2punkt0.de/ . Accessed 13 Sept 2023.
German Pain Society (Deutsche Schmerzgesellschaft e.V. https://www.schmerzgesellschaft.de/fileadmin/2022/PDFs/DSF_Handbuch_2022.pdf . Accessed 20 Sept 2023.
Twisk J. Applied longitudinal data analysis for epidemiology. Cambridge: Cambridge University Press; 2003.
Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. College Station: STATA press; 2008.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin J, Doré C, Parulekar W, Summerskill W, Groves T, Schulz K, Sox H, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7.
doi: 10.7326/0003-4819-158-3-201302050-00583
pubmed: 23295957
pmcid: 5114123
Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin J, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleža-Jerić K, Laupacis A, Moher D. SPIRIT 2013 Explanation and Elaboration: Guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
doi: 10.1136/bmj.e7586
pubmed: 23303884
pmcid: 3541470
Schulz KF, Altman DG, Moher D and the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010. https://doi.org/10.1186/1741-7015-8-18 .
Elbers S, Wittink H, Konings S, Kaiser U, Kleijnen J, Pool J, Köke A, Smeets R. Longitudinal outcome evaluations of Interdisciplinary Multimodal Pain Treatment programmes for patients with chronic primary musculoskeletal pain: a systematic review and meta-analysis. Eur J Pain. 2022;26(2):310–35.
doi: 10.1002/ejp.1875
pubmed: 34624159